Use of aspirin and low-molecular-weight heparin to prevent recurrence of maternal floor infarction in women without evidence of antiphospholipid antibody syndrome

Fetal Diagnosis and Therapy

Volumn 19, Issue 3, 2004, Pages 261-265

  Makino, Aiko ^a   Suzuki, Yoshikatu ^a   Yamamoto, Tamao ^a   Sato, Takeshi ^a   Kojima, Kazuhisa ^a   Suzumori, Kaoru ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Anticoagulant; Intrauterine growth retardation; Maternal floor infarction

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY; RITODRINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CESAREAN SECTION; CHILD DEATH; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; DISEASE COURSE; DRUG INFUSION; FEMALE; FETUS MONITORING; HISTOLOGY; HUMAN; IMAGE ANALYSIS; INFARCTION; LABORATORY TEST; LOW DRUG DOSE; MATERNAL FLOOR INFARCTION; MOTHER; PATIENT ATTITUDE; PELVIS FLOOR; PHOSPHOLIPID ANTIBODY SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; SECOND TRIMESTER PREGNANCY; SYNDROME; UTERUS CONTRACTION;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFARCTION; MAGNETIC RESONANCE IMAGING; PELVIC FLOOR; PLACENTA; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RECURRENCE; ULTRASONOGRAPHY, PRENATAL;

EID: 1842635529     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076708     Document Type: Article

References (13)

1. Naeye RL: Maternal floor infarction. Hum Pathol 1985;16:823-828.
2. Katzman PJ, Genest D: Maternal floor infarction and massive perivillous fibrin deposition: Histological definitions, association with intrauterine fetal growth restriction, and risk of recurrence. Pediatr Dev Pathol 2002;5:159-164.
3. Cunningham FG, et al: Hypertensive disorders in pregnancy; in Cunningham FG (ed): Williams Obstetrics, ed 21. New York, McGraw-Hill, 2001, pp 567-618.
4. Bendon RW, Hommel AB: Maternal floor infarction in autoimmune disease: Two cases. Pediatr Pathol Lab Med 1996;16:293-297.
5. Andres RL, Kuyper W, Resnik R: The association of maternal floor infarction of the placenta with adverse prenatal outcome. Am J Obstet Gynecol 1990;163:935-938.
6. Cowchock S: Treatment of antiphospholipid syndrome in pregnancy. Lupus 1998;7:S95-S97.
7. Kojima K, Suzuki Y, Makino A, Murakami I, Suzumori K: A case of massive subchorionic thrombohematoma diagnosed by ultrasonography and magnetic resonance imaging. Fetal Diagn Ther 2001;16:57-60.
8. Ogawa Y, et al: Birth size standards by gestational general age for Japanese neonates. Nihon Siniseijigakkaishi 1998;34:624.
9. Ogasawara M, Sasa H, Katano K, Aoyama T, Aoki K, Suzumori K: Recurrent abortion and moderate or strong antiphospholipid antibody production. Int J Gynaecol Obstet 1998;62:183-188.
10. Ebina Y, Yamada H, Kato EH, Yamamoto R, Sakuragi N, Fujimoto S: Thromboprophylaxis with low molecular weight heparin in thrombophilia- complicated pregnancy. J Obstet Gynaecol Res 2002;5:251-257.
11. Suzuki Y, Hattori T, Kajikuri J, Yamamoto T, Suzumori K, Itoh T: Reduced function of endothelial prostacyclin in human omental resistance arteries in pre-eclampsia. J Physiol 2002;545:269-277.
12. Sauer I, Reiste F, Heyl W, Funk A: Significance of detecting impaired uteroplacental perfusion for diagnosis of antiphospholipid antibody syndrome - A case report. Z Geburtshilfe Neonatol 2000;204:198-201.
13. Hunt BJ, Doughty HA, Majumdar G, Copplestone A, Kerslake S, Buchanan N: Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost 1997;77:39-43.